5 completed, 4 unknown, 2 not yet recruiting, 1 active not recruiting. 7 Phase 2, 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Unknown 3, Completed 2, Active not recruiting 1, Not yet recruiting 1 |
| Phase 1 | 6 | Completed 3, Not yet recruiting 1, Unknown 1, Withdrawn 1 |
Follow Encephalomyelitis, Equine: new trials by email Literature Review of Encephalomyelitis, Equine trials Research Report on Encephalomyelitis, Equine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers V4020 - Venezuelan Equine Encephalitis, Venezuelan Equine Encephalitis Virus Infection | Phase 1 | Not yet recruiting | Medigen, Inc. | 39 | 2025-08-15 | 2025-07-28 |
| A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine MVA-BN-WEV, Placebo - Encephalitis | Phase 2 | Active not recruiting | Bavarian Nordic | 411 | 2025-03-10 | 2025-10-01 |
| Safety and Immunogenicity Study of Venezuelan Equine Encephalomyelitis (VEE) Vaccine as Booster Vaccine in Adults 0.5 mL Inactivated, Dried, C-84, TSI-GSD 205, Lot 7, Run 1 - Venezuelan Equine Encephalomyelitis | Phase 2 | Not yet recruiting | U.S. Army Medical Research and Development Command | 500 | 2021-06-01 | 2021-02-16 |
| Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects MVA-BN-WEV Dose 1, MVA-BN-WEV Dose 2, MVA-BN-WEV Dose 3 - Equine Encephalitis | Phase 1 | Completed | Bavarian Nordic | 45 | 2019-10-07 | 2020-08-20 |
| VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults VRC-WEVVLP073-00-VP, VRC-GENMIX083-AL-VP - Venezuelan Equine Encephalitis, Western Equine Encephalitis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 30 | 2019-04-02 | 2021-03-24 |
| Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine Vaccinations on Day 0, Day 28, and Day 140 - Encephalitis, Encephalitis, Viral | Phase 1 | Unknown | SRI International | 48 | 2018-07-17 | 2021-02-23 |
| Safety and Immunogenicity Study of the Western Equine Encephalitis (WEE) Vaccine Western Equine Encephalitis (WEE) Vaccine - Western Equine Encephalitis | Phase 2 | Unknown | U.S. Army Medical Research and Development Command | 500 | 2015-12-15 | 2021-02-11 |
| Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers Venezuelan Equine Encephalitis Virus DNA Vaccine Candidate, 0.9% saline placebo - Venezuelan Equine Encephalitis Virus Infection | Phase 1 | Completed | Ichor Medical Systems Incorporated | 42 | 2013-12-01 | 2015-08-26 |
| Safety and Immunogenicity Study of Eastern Equine Encephalitis (EEE) Vaccine Inactivated, Dried, TSI-GSD 104, EEE - Eastern Equine Encephalitis | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 138 | 2008-06-03 | 2019-09-24 |
| Safety and Immunogenicity Study of the Eastern Equine Encephalitis (EEE) Vaccine Eastern Equine Encephalitis Vaccine, Inactivated, Dried, TSI-GSD 104 - Eastern Equine Encephalitis | Phase 2 | Completed | U.S. Army Medical Research and Development Command | 138 | 2008-06-03 | 2020-03-17 |
| Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine (VEE C-84) as a Booster to VEE TC-83 VEE C-84 - Venezuelan Equine Encephalomyelitis | Phase 2 | Unknown | U.S. Army Medical Research and Development Command | 500 | 2008-03-01 | 2021-02-11 |
| Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine VEE TC-83 - Venezuelan Equine Encephalomyelitis | Phase 2 | Unknown | U.S. Army Medical Research and Development Command | 500 | 2007-09-01 | 2021-02-11 |
| Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine VEE 3526 - Venezuelan Equine Encephalitis | Phase 1 | Withdrawn | DynPort Vaccine Company LLC, A GDIT Company | 2005-07-01 | 2015-09-18 |
Encephalomyelitis, Venezuelan Equine (8) · Alphavirus Infections (3) · Encephalitis (3) · Encephalomyelitis, Eastern Equine (3) · Encephalomyelitis, Western Equine (2) · Nervous System Diseases (2) · Virus Diseases (2) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Infections (1) · Central Nervous System Viral Diseases (1) · Encephalitis, Viral (1) · Encephalomyelitis (1) · Infectious Encephalitis (1)
Arbovirus Infections (13) · Encephalitis, Arbovirus (13) · Infections (13) · Mosquito-Borne Diseases (13) · Neuroinflammatory Diseases (13) · Vector Borne Diseases (13) · Brain Diseases (12) · Central Nervous System Diseases (12) · Central Nervous System Infections (12) · Central Nervous System Viral Diseases (12) · Encephalitis, Viral (12) · Encephalomyelitis (12) · Infectious Encephalitis (12) · RNA Virus Infections (12) · Togaviridae Infections (12)
Desiccation (3) · Vaccines (1) · aluminum sulfate (1)
U.S. Army Medical Research and Development Command (6) · Bavarian Nordic (2) · DynPort Vaccine Company LLC, A GDIT Company (1) · Ichor Medical Systems Incorporated (1) · Medigen, Inc. (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · SRI International (1)
United States (13)
Anthony Cardile, DO (2) · Robert Rivard, MD (2) · Anthony P Cardile, DO, MAJ (1) · Carlos A. Fierro, MD (1) · Carlos Fierro, MD (1) · Grace Chen, MD (1) · Julie E Ledgerwood, DO (1) · Ronald Reisler, MD (1) · Sascha Goonewardena, MD (1)
PMID 27206386, PMID 33899755, PMID 35568049, PMID 38494412, PMID 5063895